DrugPatentWatch Database Preview
Biologic Drugs With Mechanism of Action: Interleukin 17 Receptor A Antagonists
» See Plans and Pricing
Biologic Drugs With Mechanism of Action: Interleukin 17 Receptor A Antagonists
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Luxembourg | SILIQ | brodalumab | INJECTABLE;INJECTION | 761032 | 001 | 2017-06-08 | Start Trial | InCube Labs, LLC (San Jose, CA) | 2034-05-15 | RX | search | |
Valeant Luxembourg | SILIQ | brodalumab | INJECTABLE;INJECTION | 761032 | 001 | 2017-06-08 | Start Trial | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | search | |
Valeant Luxembourg | SILIQ | brodalumab | INJECTABLE;INJECTION | 761032 | 001 | 2017-06-08 | Start Trial | THERASYN SENSORS, INC. (Eggertsville, NY) | 2033-03-14 | RX | search | |
Valeant Luxembourg | SILIQ | brodalumab | INJECTABLE;INJECTION | 761032 | 001 | 2017-06-08 | Start Trial | The Regents of the University of California (Oakland, CA) | 2035-02-24 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |